1. Home
  2. CURR vs PMVP Comparison

CURR vs PMVP Comparison

Compare CURR & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CURR
  • PMVP
  • Stock Information
  • Founded
  • CURR 2013
  • PMVP 2013
  • Country
  • CURR Singapore
  • PMVP United States
  • Employees
  • CURR N/A
  • PMVP N/A
  • Industry
  • CURR Business Services
  • PMVP Medicinal Chemicals and Botanical Products
  • Sector
  • CURR Consumer Discretionary
  • PMVP Health Care
  • Exchange
  • CURR Nasdaq
  • PMVP Nasdaq
  • Market Cap
  • CURR 89.8M
  • PMVP 85.5M
  • IPO Year
  • CURR N/A
  • PMVP 2020
  • Fundamental
  • Price
  • CURR $1.34
  • PMVP $1.52
  • Analyst Decision
  • CURR
  • PMVP Strong Buy
  • Analyst Count
  • CURR 0
  • PMVP 4
  • Target Price
  • CURR N/A
  • PMVP $5.75
  • AVG Volume (30 Days)
  • CURR 10.5K
  • PMVP 196.4K
  • Earning Date
  • CURR 02-11-2025
  • PMVP 11-07-2024
  • Dividend Yield
  • CURR N/A
  • PMVP N/A
  • EPS Growth
  • CURR N/A
  • PMVP N/A
  • EPS
  • CURR N/A
  • PMVP N/A
  • Revenue
  • CURR $55,500,917.00
  • PMVP N/A
  • Revenue This Year
  • CURR N/A
  • PMVP N/A
  • Revenue Next Year
  • CURR N/A
  • PMVP N/A
  • P/E Ratio
  • CURR N/A
  • PMVP N/A
  • Revenue Growth
  • CURR N/A
  • PMVP N/A
  • 52 Week Low
  • CURR $1.20
  • PMVP $1.40
  • 52 Week High
  • CURR $5.74
  • PMVP $3.47
  • Technical
  • Relative Strength Index (RSI)
  • CURR N/A
  • PMVP 39.62
  • Support Level
  • CURR N/A
  • PMVP $1.55
  • Resistance Level
  • CURR N/A
  • PMVP $1.61
  • Average True Range (ATR)
  • CURR 0.00
  • PMVP 0.07
  • MACD
  • CURR 0.00
  • PMVP -0.01
  • Stochastic Oscillator
  • CURR 0.00
  • PMVP 5.56

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech banking platform for e-wallets, financial institutions and merchants worldwide, delivering frictionless interoperable real-time fund transfers and instant messaging.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

Share on Social Networks: